| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 2.96e-15 | 11 | 165 | 8 | GO:0098973 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 3.44e-12 | 32 | 165 | 9 | GO:0099186 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 5.09e-11 | 42 | 165 | 9 | GO:0098918 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 1.35e-06 | 130 | 165 | 9 | GO:0005200 | |
| GeneOntologyMolecularFunction | chloride channel activity | 7.19e-06 | 86 | 165 | 7 | GO:0005254 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.28e-05 | 171 | 165 | 9 | GO:0015103 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 2.36e-05 | 103 | 165 | 7 | GO:0005253 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 5.69e-05 | 50 | 165 | 5 | GO:0099095 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 8.16e-05 | 125 | 165 | 7 | GO:0015108 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC25A24 CACNA1E ANO2 ATP7A TTYH2 ANO1 CLCC1 RYR3 SLC45A4 SLC30A6 TPCN1 CLCN7 GET3 ATP2A2 ATP5F1B GABRA4 GABRA6 | 1.86e-04 | 758 | 165 | 17 | GO:0015318 |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 2.64e-04 | 151 | 165 | 7 | GO:0008509 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated channel activity | 5.70e-04 | 20 | 165 | 3 | GO:0141147 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated chloride channel activity | 5.70e-04 | 20 | 165 | 3 | GO:0005229 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC25A24 CACNA1E ANO2 ATP7A ABCA13 TTYH2 ANO1 CLCC1 RYR3 SLC45A4 SLC30A6 TPCN1 CLCN7 ABCA5 GET3 ATP2A2 SLC22A20P SLC25A48 ATP5F1B GABRA4 GABRA6 | 7.44e-04 | 1180 | 165 | 21 | GO:0022857 |
| GeneOntologyMolecularFunction | carnitine O-acyltransferase activity | 9.96e-04 | 6 | 165 | 2 | GO:0016406 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DDX59 ATP7A ABCA13 ACTB UPF1 IFIH1 ABCA5 GET3 ATP2A2 DYNC1H1 ATP5F1B | 1.13e-03 | 441 | 165 | 11 | GO:0016887 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.14e-03 | 193 | 165 | 7 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.28e-03 | 197 | 165 | 7 | GO:0022834 | |
| GeneOntologyMolecularFunction | protein kinase activity | ANKK1 TSSK6 HUNK PIK3R4 JAK2 GUCY2C PIK3CA STK33 TBK1 PRKAA1 NIM1K PEAK1 PAN3 | 1.47e-03 | 600 | 165 | 13 | GO:0004672 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1E ANO2 TTYH2 ANO1 CLCC1 RYR3 TPCN1 CLCN7 ATP5F1B GABRA4 GABRA6 | 1.55e-03 | 459 | 165 | 11 | GO:0005216 |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 1.00e-10 | 31 | 166 | 8 | GO:0098974 | |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 2.91e-10 | 35 | 166 | 8 | GO:0099188 | |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 3.44e-05 | 112 | 166 | 7 | GO:1902476 | |
| GeneOntologyBiologicalProcess | postsynapse organization | RAPSN POTEF ACTBL2 ACTB ACTG1 POTEKP POTEE UBE3A CHRDL1 POTEI POTEJ | 4.83e-05 | 313 | 166 | 11 | GO:0099173 |
| GeneOntologyBiologicalProcess | chloride transport | 8.05e-05 | 128 | 166 | 7 | GO:0006821 | |
| GeneOntologyBiologicalProcess | glucosylceramide metabolic process | 1.07e-04 | 12 | 166 | 3 | GO:0006678 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 1.07e-04 | 134 | 166 | 7 | GO:0098661 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | ARHGAP32 ATP7A MYO7A POTEF ACTBL2 ACTB ACTG1 NFASC NR4A3 POTEKP ARHGEF25 POTEE UBE3A POTEI POTEJ NOTCH2 SOS1 | 1.16e-04 | 748 | 166 | 17 | GO:0048667 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | ARHGAP32 ATP7A POTEF ACTBL2 ACTB ANO1 ACTG1 NFASC NR4A3 POTEKP ARHGEF25 POTEE UBE3A DMD POTEI POTEJ NOTCH2 SOS1 | 1.23e-04 | 826 | 166 | 18 | GO:0048858 |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 1.14e-10 | 32 | 165 | 8 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 1.14e-10 | 32 | 165 | 8 | GO:0043189 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 2.14e-09 | 45 | 165 | 8 | GO:1902562 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 5.73e-08 | 94 | 165 | 9 | GO:0000123 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 1.38e-07 | 104 | 165 | 9 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 2.07e-07 | 109 | 165 | 9 | GO:1902493 | |
| GeneOntologyCellularComponent | chloride channel complex | 3.19e-07 | 57 | 165 | 7 | GO:0034707 | |
| GeneOntologyCellularComponent | actin filament | 2.13e-05 | 146 | 165 | 8 | GO:0005884 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | CACNA1E ANO2 TTYH2 ANO1 CLCC1 RYR3 TPCN1 CLCN7 CPT1C ATP5F1B GABRA4 GABRA6 | 4.85e-05 | 378 | 165 | 12 | GO:0034702 |
| GeneOntologyCellularComponent | membrane protein complex | CACNA1E ANO2 TREX1 GPAA1 TTYH2 ANO1 NAPG ITGA6 ITGAE ITGB5 CLCC1 RYR3 TPCN1 PIK3R4 JAK2 DUOX1 CLCN7 PIK3CA CPT1C SYNE2 DMD ATP2A2 ATP5F1B MVB12B GABRA4 GABRA6 | 1.19e-04 | 1498 | 165 | 26 | GO:0098796 |
| GeneOntologyCellularComponent | transmembrane transporter complex | CACNA1E ANO2 TTYH2 ANO1 CLCC1 RYR3 TPCN1 CLCN7 CPT1C ATP2A2 ATP5F1B GABRA4 GABRA6 | 2.71e-04 | 523 | 165 | 13 | GO:1902495 |
| GeneOntologyCellularComponent | transporter complex | CACNA1E ANO2 TTYH2 ANO1 CLCC1 RYR3 TPCN1 CLCN7 CPT1C ATP2A2 ATP5F1B GABRA4 GABRA6 | 4.38e-04 | 550 | 165 | 13 | GO:1990351 |
| GeneOntologyCellularComponent | blood microparticle | 1.00e-03 | 144 | 165 | 6 | GO:0072562 | |
| GeneOntologyCellularComponent | dense body | 1.27e-03 | 7 | 165 | 2 | GO:0097433 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | TREX1 ARHGAP32 ACER1 GPAA1 EXTL2 MBOAT2 CLCC1 RYR3 GUCY2C CPT1C SCARB2 GET3 SYNE2 SEC16A UGT2B4 UGT2B7 WDR83OS ATP2A2 OR7A10 NOTCH2 OR2W6P | 1.32e-03 | 1293 | 165 | 21 | GO:0005789 |
| GeneOntologyCellularComponent | chromatin | POTEF ACTBL2 ACTB ACTG1 NR4A3 POTEKP UPF1 LHX8 SIX1 CLOCK ZFPM2 HOXA4 JAK2 POTEE HOXB4 GRHL1 PRDM10 PRKAA1 TADA2A POTEI POTEJ USF2 SIX2 | 1.39e-03 | 1480 | 165 | 23 | GO:0000785 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | TREX1 ARHGAP32 ACER1 GPAA1 EXTL2 MBOAT2 CLCC1 RYR3 GUCY2C CPT1C SCARB2 GET3 SYNE2 SEC16A UGT2B4 UGT2B7 WDR83OS ATP2A2 OR7A10 NOTCH2 OR2W6P | 1.40e-03 | 1299 | 165 | 21 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | TREX1 ARHGAP32 ACER1 GPAA1 EXTL2 MBOAT2 CLCC1 RYR3 GUCY2C CPT1C SCARB2 GET3 SYNE2 SEC16A UGT2B4 UGT2B7 WDR83OS ATP2A2 OR7A10 NOTCH2 OR2W6P | 1.82e-03 | 1327 | 165 | 21 | GO:0042175 |
| GeneOntologyCellularComponent | axon | ATP7A POTEF ACTBL2 ACTB ACTG1 NFASC POTEKP POTEE CPT1C PRKAA1 GLUL MRGPRX4 DMD POTEI POTEJ DYNC1H1 | 1.88e-03 | 891 | 165 | 16 | GO:0030424 |
| GeneOntologyCellularComponent | integrin complex | 2.02e-03 | 32 | 165 | 3 | GO:0008305 | |
| Domain | Actin_CS | 3.79e-11 | 16 | 164 | 7 | IPR004001 | |
| Domain | ACTINS_2 | 6.39e-11 | 17 | 164 | 7 | PS00432 | |
| Domain | Actin/actin-like_CS | 1.04e-10 | 18 | 164 | 7 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 1.63e-10 | 19 | 164 | 7 | PS01132 | |
| Domain | Actin | 7.80e-09 | 31 | 164 | 7 | IPR004000 | |
| Domain | Actin | 7.80e-09 | 31 | 164 | 7 | PF00022 | |
| Domain | ACTIN | 7.80e-09 | 31 | 164 | 7 | SM00268 | |
| Domain | ACTINS_1 | 3.60e-05 | 8 | 164 | 3 | PS00406 | |
| Domain | Kinase-like_dom | ANKK1 TSSK6 HUNK PIK3R4 JAK2 GUCY2C PIK3CA STK33 TBK1 PRKAA1 NIM1K PEAK1 DMD PAN3 SOS1 | 8.93e-05 | 542 | 164 | 15 | IPR011009 |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 3.51e-04 | 69 | 164 | 5 | IPR020636 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 1.01e-05 | 83 | 128 | 7 | M8728 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 5.57e-05 | 74 | 128 | 6 | M16376 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 5.57e-05 | 74 | 128 | 6 | M39462 | |
| Pathway | KEGG_MEDICUS_VARIANT_DELETED_DMD_TO_DYSTROPHIN_ASSOCIATED_PROTEIN_COMPLEX | 8.38e-05 | 10 | 128 | 3 | M47575 | |
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 1.57e-15 | 15 | 168 | 8 | 16824795 | |
| Pubmed | CACNA1E ARHGAP32 DMXL2 DNAJC13 ACTB ARHGEF18 NFASC UPF1 ITIH1 ITIH4 FARSA STRAP UBE3A TBK1 SYNE2 SEC16A GLUL UBASH3B NEURL4 DYNC1H1 RASAL2 | 9.63e-09 | 963 | 168 | 21 | 28671696 | |
| Pubmed | 6.50e-08 | 9 | 168 | 4 | 16364570 | ||
| Pubmed | Evolution and expression of chimeric POTE-actin genes in the human genome. | 1.11e-07 | 3 | 168 | 3 | 17101985 | |
| Pubmed | ARHGAP32 IRS4 ATP7A ITGA6 GFOD2 PIK3CA SEC16A PEAK1 DMD GNS NOTCH2 RASAL2 MVB12B | 1.55e-07 | 421 | 168 | 13 | 36976175 | |
| Pubmed | ARHGAP32 DNAJC13 IRS4 NUP107 ACTBL2 ACTB NOC3L ITGA6 ACTG1 CLCC1 PTPN2 CLCN7 SYNE2 SEC16A USP7 PEAK1 DMD ATP2A2 NEURL4 SIX2 | 1.95e-07 | 1049 | 168 | 20 | 27880917 | |
| Pubmed | Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. | POTEF ACTBL2 ACTB ACTG1 POTEKP POTEE PIK3CA EIF3B UBASH3B ATP2A2 | 5.32e-07 | 256 | 168 | 10 | 24189400 |
| Pubmed | 5.44e-07 | 197 | 168 | 9 | 31620119 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 6.71e-07 | 202 | 168 | 9 | 33005030 | |
| Pubmed | 6.71e-07 | 202 | 168 | 9 | 24639526 | ||
| Pubmed | SLC25A24 IRS4 NUP107 ACTB UPF1 NUP205 FARSA SCARB2 PRKAA1 USP7 EIF3B DYNC1H1 ATP5F1B | 7.50e-07 | 484 | 168 | 13 | 31995728 | |
| Pubmed | 8.30e-07 | 66 | 168 | 6 | 27371349 | ||
| Pubmed | Upregulation of RIN3 induces endosomal dysfunction in Alzheimer's disease. | IRS4 ACTB ACTG1 NUP205 STRAP GET3 XPNPEP3 GLUL POTEJ ATP2A2 DYNC1H1 ATP5F1B | 1.02e-06 | 418 | 168 | 12 | 32552912 |
| Pubmed | 1.42e-06 | 40 | 168 | 5 | 27197753 | ||
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | IRS4 POTEF ACTBL2 ACTB POTEKP POTEE POTEI POTEJ DYNC1H1 ATP5F1B | 1.54e-06 | 288 | 168 | 10 | 31501420 |
| Pubmed | 2.19e-06 | 6 | 168 | 3 | 33002761 | ||
| Pubmed | Six1 homeoprotein drives myofiber type IIA specialization in soleus muscle. | 4.40e-06 | 50 | 168 | 5 | 27597886 | |
| Pubmed | SLC25A24 ACP6 ACOT13 POTEF ACTB ITGA6 POTEKP UPF1 CRAT ITGB5 STRAP SCARB2 COQ9 GLUL ATP2A2 ATP5F1B | 4.69e-06 | 859 | 168 | 16 | 31536960 | |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | IRS4 ZCCHC8 ACTBL2 ACTB NUP205 PTPN2 SEC16A EIF3B PEAK1 POTEI ATP2A2 DYNC1H1 ATP5F1B | 4.77e-06 | 573 | 168 | 13 | 28330616 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SLC25A24 IRS4 NUP107 ACOT13 NOC3L ACTG1 UPF1 NUP205 PIK3R4 GBA3 FARSA STRAP TBK1 GLUL USP7 EIF3B PEAK1 ATP2A2 DYNC1H1 RASAL2 ATP5F1B | 5.76e-06 | 1425 | 168 | 21 | 30948266 |
| Pubmed | ARHGAP32 DMXL2 DNAJC13 MYO7A ACTBL2 ACTB ACTG1 NFASC UPF1 PIK3R4 FARSA PRKAA1 SEC16A GLUL USP7 PEAK1 DMD ATP2A2 DYNC1H1 RASAL2 ATP5F1B | 6.14e-06 | 1431 | 168 | 21 | 37142655 | |
| Pubmed | DMXL2 DNAJC13 ATP7A ITGA6 CLCC1 SLC30A6 PIK3R4 CLCN7 SYNE2 SEC16A NOTCH2 RASAL2 | 6.90e-06 | 504 | 168 | 12 | 34432599 | |
| Pubmed | IRS4 ZCCHC8 POTEF ACTBL2 ACTB USP7 EIF3B TADA2A POTEI POTEJ DYNC1H1 ATP5F1B | 7.18e-06 | 506 | 168 | 12 | 30890647 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | USP24 ACTG1 GBE1 UPF1 STRAP USP7 EIF3B UBASH3B DYNC1H1 ATP5F1B | 7.43e-06 | 344 | 168 | 10 | 30333137 |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | IRS4 USP24 ACTG1 NUP205 FARSA STRAP USP7 ATP2A2 DYNC1H1 ATP5F1B | 7.43e-06 | 344 | 168 | 10 | 36282215 |
| Pubmed | 7.52e-06 | 96 | 168 | 6 | 23580065 | ||
| Pubmed | Repression of rRNA transcription by PARIS contributes to Parkinson's disease. | 7.67e-06 | 272 | 168 | 9 | 25315684 | |
| Pubmed | 8.54e-06 | 149 | 168 | 7 | 22664934 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | DNAJC13 RBMS2 NOC3L NAPG ITGA6 FRYL UPF1 CLCC1 NUP205 PTPN2 NLN SCARB2 GET3 SYNE2 A2ML1 PRKAA1 SEC16A ATP2A2 GNS ATP5F1B | 1.09e-05 | 1367 | 168 | 20 | 32687490 |
| Pubmed | 1.13e-05 | 103 | 168 | 6 | 21706016 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | ACP6 IRS4 NUP107 ACTB ACTG1 RRAGB UPF1 NUP205 PIK3R4 FARSA STRAP UBE3A SEC16A GLUL USP7 EIF3B ATP2A2 DYNC1H1 ATP5F1B | 1.17e-05 | 1257 | 168 | 19 | 37317656 |
| Pubmed | 1.19e-05 | 104 | 168 | 6 | 9205841 | ||
| Pubmed | 1.48e-05 | 225 | 168 | 8 | 12168954 | ||
| Pubmed | DNAJC13 IRS4 NUP107 ACTB USP24 UPF1 NUP205 STRAP USP7 EIF3B ATP2A2 DYNC1H1 ATP5F1B | 1.49e-05 | 638 | 168 | 13 | 33239621 | |
| Pubmed | 1.78e-05 | 11 | 168 | 3 | 7720577 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | POTEF ACTB ACTG1 GBE1 POTEKP ITGB5 ITIH1 ITIH4 POTEE BTD SCARB2 SCGB1A1 POTEI POTEJ GNS DYNC1H1 ATP5F1B | 1.85e-05 | 1070 | 168 | 17 | 23533145 |
| Pubmed | IRS4 NUP107 ZCCHC8 NOC3L USP24 FRYL UPF1 NUP205 SYNE2 SEC16A USP7 ATP2A2 DYNC1H1 | 1.90e-05 | 653 | 168 | 13 | 22586326 | |
| Pubmed | Beta- and gamma-cytoplasmic actins are required for meiosis in mouse oocytes. | 2.32e-05 | 2 | 168 | 2 | 21778137 | |
| Pubmed | De novo mutations in the actin genes ACTB and ACTG1 cause Baraitser-Winter syndrome. | 2.32e-05 | 2 | 168 | 2 | 22366783 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 10222050 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 23570556 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 20886252 | ||
| Pubmed | Circadian regulator CLOCK promotes tumor angiogenesis in glioblastoma. | 2.32e-05 | 2 | 168 | 2 | 36795563 | |
| Pubmed | HOXA4 provides stronger engraftment potential to short-term repopulating cells than HOXB4. | 2.32e-05 | 2 | 168 | 2 | 26166023 | |
| Pubmed | A primate-specific POTE-actin fusion protein plays a role in apoptosis. | 2.32e-05 | 2 | 168 | 2 | 19669888 | |
| Pubmed | A time to fast, a time to feast: the crosstalk between metabolism and the circadian clock. | 2.32e-05 | 2 | 168 | 2 | 19714310 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 3221869 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 35129434 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 17263731 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 21901130 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 15319348 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 21502360 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 6686106 | ||
| Pubmed | The transcription factor NR4A3 controls CD103+ dendritic cell migration. | 2.32e-05 | 2 | 168 | 2 | 27820700 | |
| Pubmed | Beta and gamma-cytoplasmic actins display distinct distribution and functional diversity. | 2.32e-05 | 2 | 168 | 2 | 19638415 | |
| Pubmed | Botulinum C2 toxin ADP-ribosylates cytoplasmic beta/gamma-actin in arginine 177. | 2.32e-05 | 2 | 168 | 2 | 3335520 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 1577857 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 24997346 | ||
| Pubmed | Aicardi goutières syndrome is associated with pulmonary hypertension. | 2.32e-05 | 2 | 168 | 2 | 30219631 | |
| Pubmed | Severe forms of Baraitser-Winter syndrome are caused by ACTB mutations rather than ACTG1 mutations. | 2.32e-05 | 2 | 168 | 2 | 23756437 | |
| Pubmed | Cytochalasin D-induced actin gene expression in murine erythroleukemia cells. | 2.32e-05 | 2 | 168 | 2 | 8482333 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 29265728 | ||
| Pubmed | Potent Antineoplastic Effects of Combined PI3Kα-MNK Inhibition in Medulloblastoma. | 2.32e-05 | 2 | 168 | 2 | 30842251 | |
| Pubmed | Multi-isotope imaging mass spectrometry reveals slow protein turnover in hair-cell stereocilia. | 2.32e-05 | 2 | 168 | 2 | 22246323 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 25489088 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 32349449 | ||
| Pubmed | Baraitser-Winter cerebrofrontofacial syndrome: Report of two adult siblings. | 2.32e-05 | 2 | 168 | 2 | 32506774 | |
| Pubmed | Differential arginylation of actin isoforms is regulated by coding sequence-dependent degradation. | 2.32e-05 | 2 | 168 | 2 | 20847274 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 22190591 | ||
| Pubmed | Mutational analysis of PIK3CA, JAK2, BRAF, FOXL2, IDH1, AKT1 and EZH2 oncogenes in sarcomas. | 2.32e-05 | 2 | 168 | 2 | 22779686 | |
| Pubmed | Circadian regulation of allergic reactions by the mast cell clock in mice. | 2.32e-05 | 2 | 168 | 2 | 24060274 | |
| Pubmed | Prenatal presentation and diagnosis of Baraitser-Winter syndrome using exome sequencing. | 2.32e-05 | 2 | 168 | 2 | 32588558 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 24318978 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 33281191 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 27625340 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 16323283 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 24928056 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 36625485 | ||
| Pubmed | Circadian Rhythms and Sleep Are Dependent Upon Expression Levels of Key Ubiquitin Ligase Ube3a. | 2.32e-05 | 2 | 168 | 2 | 35401134 | |
| Pubmed | Local receptors as novel regulators for peripheral clock expression. | 2.32e-05 | 2 | 168 | 2 | 25145629 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 36334706 | ||
| Pubmed | Increased FOG-2 in failing myocardium disrupts thyroid hormone-dependent SERCA2 gene transcription. | 2.32e-05 | 2 | 168 | 2 | 18658259 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 27796320 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 213279 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 33334799 | ||
| Pubmed | β-Actin specifically controls cell growth, migration, and the G-actin pool. | 2.32e-05 | 2 | 168 | 2 | 21900491 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 26194231 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 28821839 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 9288906 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 29339832 | ||
| Pubmed | Interplay between myofibers and pro-inflammatory macrophages controls muscle damage in mdx mice. | 2.32e-05 | 2 | 168 | 2 | 34471933 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 26583190 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 32326615 | ||
| Pubmed | The circadian mutation PER2(S662G) is linked to cell cycle progression and tumorigenesis. | 2.32e-05 | 2 | 168 | 2 | 21818120 | |
| Pubmed | Selective POTE paralogs on chromosome 2 are expressed in human embryonic stem cells. | 2.32e-05 | 2 | 168 | 2 | 18447647 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 20930542 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 22500639 | ||
| Pubmed | Skeletal muscle-specific ablation of gamma(cyto)-actin does not exacerbate the mdx phenotype. | 2.32e-05 | 2 | 168 | 2 | 18545671 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 2837653 | ||
| Pubmed | Role of intestinal circadian genes in alcohol-induced gut leakiness. | 2.32e-05 | 2 | 168 | 2 | 21463335 | |
| Interaction | ACTG2 interactions | 1.40e-07 | 49 | 165 | 7 | int:ACTG2 | |
| Interaction | CAP2 interactions | 1.13e-06 | 66 | 165 | 7 | int:CAP2 | |
| Interaction | POTEJ interactions | 4.10e-06 | 52 | 165 | 6 | int:POTEJ | |
| Interaction | SCIN interactions | 7.83e-06 | 58 | 165 | 6 | int:SCIN | |
| Interaction | SHC1 interactions | ARHGAP32 ACTB ACTG1 JAK2 PTPN2 CD22 PRKAA1 SEC16A USP7 PEAK1 UBASH3B RASAL2 SOS1 | 9.31e-06 | 362 | 165 | 13 | int:SHC1 |
| Interaction | NKX6-3 interactions | 1.06e-05 | 6 | 165 | 3 | int:NKX6-3 | |
| Interaction | WASH3P interactions | 2.04e-05 | 41 | 165 | 5 | int:WASH3P | |
| Interaction | ERRFI1 interactions | 2.85e-05 | 107 | 165 | 7 | int:ERRFI1 | |
| Interaction | ACTBL2 interactions | NUP107 POTEF ACTBL2 ACTB ACTG1 SLC30A6 POTEE UBE3A SCARB2 POTEI POTEJ | 3.39e-05 | 296 | 165 | 11 | int:ACTBL2 |
| Interaction | CCND2 interactions | 4.23e-05 | 155 | 165 | 8 | int:CCND2 | |
| Interaction | HTR1E interactions | 4.37e-05 | 9 | 165 | 3 | int:HTR1E | |
| Interaction | LRRC31 interactions | 4.99e-05 | 205 | 165 | 9 | int:LRRC31 | |
| Interaction | PFN3 interactions | 6.20e-05 | 10 | 165 | 3 | int:PFN3 | |
| Interaction | WASH8P interactions | 8.47e-05 | 11 | 165 | 3 | int:WASH8P | |
| Interaction | PHACTR2 interactions | 8.77e-05 | 29 | 165 | 4 | int:PHACTR2 | |
| Interaction | GJA1 interactions | ARHGAP32 IRS4 ATP7A TAS1R3 CLCC1 SLC30A6 PIK3R4 PIK3CA SYNE2 SEC16A USP7 PEAK1 NOTCH2 RASAL2 ATP5F1B | 9.31e-05 | 583 | 165 | 15 | int:GJA1 |
| Interaction | DPP4 interactions | SLC25A24 ATP7A ACTBL2 ACTB CLCC1 NUP205 CLCN7 GFOD2 SEC16A POTEJ ATP2A2 DYNC1H1 RASAL2 | 9.47e-05 | 453 | 165 | 13 | int:DPP4 |
| Interaction | LGALS9 interactions | SLC25A24 DNAJC13 IRS4 ATP7A NUP107 ACTB RRAGB UPF1 NUP205 FARSA SCARB2 USP7 EIF3B DYNC1H1 ATP5F1B | 1.02e-04 | 588 | 165 | 15 | int:LGALS9 |
| Interaction | ANKRD55 interactions | 1.13e-04 | 228 | 165 | 9 | int:ANKRD55 | |
| Interaction | RAB9A interactions | DNAJC13 CLCC1 SLC30A6 NUP205 PIK3R4 PTPN2 CLCN7 SYNE2 SEC16A USP7 ZFYVE26 PEAK1 NOTCH2 RASAL2 ATP5F1B | 1.17e-04 | 595 | 165 | 15 | int:RAB9A |
| Interaction | POTEE interactions | 1.19e-04 | 134 | 165 | 7 | int:POTEE | |
| Interaction | PHF21A interactions | ZNF536 DNAJC13 IRS4 NUP107 ZCCHC8 USP24 ZDBF2 CLOCK TBK1 SEC16A TADA2A | 1.27e-04 | 343 | 165 | 11 | int:PHF21A |
| Interaction | GC interactions | 1.54e-04 | 62 | 165 | 5 | int:GC | |
| Cytoband | 2q21.1 | 2.42e-06 | 58 | 168 | 5 | 2q21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q21 | 2.46e-04 | 151 | 168 | 5 | chr2q21 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 1.46e-08 | 13 | 120 | 5 | 685 | |
| GeneFamily | Actins | 6.44e-04 | 6 | 120 | 2 | 929 | |
| GeneFamily | SINE class homeoboxes | 6.44e-04 | 6 | 120 | 2 | 525 | |
| GeneFamily | Ankyrin repeat domain containing | 1.17e-03 | 242 | 120 | 7 | 403 | |
| GeneFamily | Anoctamins | 1.90e-03 | 10 | 120 | 2 | 865 | |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | SLC25A24 KIZ NOC3L GBE1 NR4A3 CRAT IFIH1 DUOX1 CD22 PIK3CA XPNPEP3 | 1.10e-06 | 267 | 165 | 11 | M41130 |
| Coexpression | GSE43863_NAIVE_VS_TH1_EFF_CD4_TCELL_D6_LCMV_DN | 2.76e-05 | 189 | 165 | 8 | M9724 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | STARD13 SLC25A24 DMXL2 DNAJC13 USP24 ITGA6 GBE1 FRYL CLOCK MBOAT2 PIK3R4 PTPN2 UBE3A SYNE2 USP7 DMD SOS1 | 3.04e-05 | 856 | 165 | 17 | M4500 |
| Coexpression | GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_UP | 3.57e-05 | 196 | 165 | 8 | M3243 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP | 4.12e-05 | 200 | 165 | 8 | M7417 | |
| Coexpression | GSE30083_SP1_VS_SP4_THYMOCYTE_DN | 4.12e-05 | 200 | 165 | 8 | M5030 | |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_UP | 4.12e-05 | 200 | 165 | 8 | M5777 | |
| Coexpression | GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_UP | 4.12e-05 | 200 | 165 | 8 | M4442 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.15e-07 | 179 | 168 | 8 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.91e-07 | 183 | 168 | 8 | d340ab5a77e8d819a1dfb4ca3e9a4b9bc988923c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-07 | 187 | 168 | 8 | f6217d0dd425eac76900b44a4e48f45475f3ac36 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-07 | 187 | 168 | 8 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.02e-07 | 188 | 168 | 8 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.26e-07 | 189 | 168 | 8 | 3a295c215b5c18e7c673f92b7af5be523421682c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.26e-07 | 189 | 168 | 8 | fc88c51ace7d883c01617f3f9b5fab70cc91cc09 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.78e-07 | 191 | 168 | 8 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | Bronchial_Biopsy-Epithelial|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.24e-07 | 199 | 168 | 8 | ef5d8917c8d011184830a0b8197afc6266707b37 | |
| ToppCell | facs-Aorta-Heart-24m-Endothelial-coronary_vascular_endothelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-06 | 164 | 168 | 7 | 5ee3729fab794d7acb172d14ec5d91aa1a61cd61 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.66e-06 | 175 | 168 | 7 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.81e-06 | 181 | 168 | 7 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.03e-06 | 182 | 168 | 7 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.25e-06 | 183 | 168 | 7 | f8b636391f752e379a5c5575fd898bdf0907a3b8 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.47e-06 | 184 | 168 | 7 | a6dee97ee4ef9d89e11d17339e0dadaea1210ce5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.71e-06 | 185 | 168 | 7 | d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.71e-06 | 185 | 168 | 7 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.95e-06 | 186 | 168 | 7 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.20e-06 | 187 | 168 | 7 | 2d17408b3b5f09d135084fd7ccce98e6b5ca632b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.20e-06 | 187 | 168 | 7 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.45e-06 | 188 | 168 | 7 | 4544552ebd67e9eb3e40d8511bb2b03a6e1178f8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.45e-06 | 188 | 168 | 7 | e30a4ddac0da8cdcf621d98e28e3895cd9307e7a | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.71e-06 | 189 | 168 | 7 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.98e-06 | 190 | 168 | 7 | b3bccf4dd95e986db3cee324a6737f5fcc22e8e5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.98e-06 | 190 | 168 | 7 | 11d3c31167ea71809b4cc3757a0c6ea54a448602 | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 8.26e-06 | 191 | 168 | 7 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 8.26e-06 | 191 | 168 | 7 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)|Adult / Lineage, Cell type, age group and donor | 8.84e-06 | 193 | 168 | 7 | 31c0978ba78c9516d498aec0798902e57555e557 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.84e-06 | 193 | 168 | 7 | ad3f4fcc8e2816d696cbcde744dc16500e51ccac | |
| ToppCell | droplet-Lung-LUNG-1m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.14e-06 | 194 | 168 | 7 | 621e0e8fe77ff0be83ea9287ce46e97c47e2b3b9 | |
| ToppCell | droplet-Lung-1m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.14e-06 | 194 | 168 | 7 | d16ab5f0cfe73afe6c551fd3123d14784a082f56 | |
| ToppCell | severe-unassigned|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.23e-06 | 128 | 168 | 6 | bef9cf0078fa8498d63f0723f1fa4a3c92405e10 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.46e-06 | 195 | 168 | 7 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.46e-06 | 195 | 168 | 7 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | mild_COVID-19-B_cell|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.10e-05 | 132 | 168 | 6 | 4b372483bc106aecc7b96a09131e1695e54e7dc4 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial-Astrocyte|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.11e-05 | 200 | 168 | 7 | b9bd6c4381c92bfc1bfff9aa778a62a41d08f1ef | |
| ToppCell | mild_COVID-19-B_cell|World / disease group, cell group and cell class (v2) | 1.73e-05 | 143 | 168 | 6 | 4698cc877dda9b1ef7d6f18c9adc869ef791b1d8 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Krt80_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.36e-05 | 151 | 168 | 6 | f50c5ae9dae507df750df25e151b58685fec70ce | |
| ToppCell | PND07-Immune-Immune_Myeloid-DC-maDC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.27e-05 | 160 | 168 | 6 | 7db30647b596f0c419087e6fabb9b99dcd5bddd4 | |
| ToppCell | PND07-Immune-Immune_Myeloid-DC-maDC-maDC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.27e-05 | 160 | 168 | 6 | 01f22cdb2a2f73776b7f91746e95c1850df94235 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.38e-05 | 161 | 168 | 6 | 76c993a4533362db2250c88b3ee3ede55362d54e | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.38e-05 | 161 | 168 | 6 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.75e-05 | 164 | 168 | 6 | 5638d95c7cc5e59c4a7bda30268a904a01861a5f | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.88e-05 | 165 | 168 | 6 | 1d0f60bf47a40ac916f0fcb5532a968742a0edbb | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-05 | 170 | 168 | 6 | 3ad9f950b87ee98f025ab9b4a8ed551e6a9b4764 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-05 | 173 | 168 | 6 | c63a615998d13b1725b5767f4ad2ec7e2b61db68 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-05 | 173 | 168 | 6 | 3612772632ddf11eb48579cae9a8ccab6b3f1f52 | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 5.05e-05 | 173 | 168 | 6 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-05 | 173 | 168 | 6 | 4dc261ebcdb9bdcfca1451da1bd254f0dc5de203 | |
| ToppCell | 10x5'-blood-Mast-Mast_cells|blood / Manually curated celltypes from each tissue | 5.22e-05 | 174 | 168 | 6 | a5838821bba2be790d32331ff529d466e9974268 | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.22e-05 | 174 | 168 | 6 | 40bb87d219aafab0357ab0d797efd38085fc0312 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.22e-05 | 174 | 168 | 6 | ebe6ce173ad12d4a2afa39f8d6185c0e4f97fb1e | |
| ToppCell | 10x5'-blood-Mast|blood / Manually curated celltypes from each tissue | 5.22e-05 | 174 | 168 | 6 | 3a8a253213b207e3ff56f94a74996b8d9ad47aa1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.39e-05 | 175 | 168 | 6 | 910a075ccaf79de22338ecf321fa0a867f3d7d75 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.39e-05 | 175 | 168 | 6 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.39e-05 | 175 | 168 | 6 | f0c2eb82e17e8aec2cfa5d83169178f409cc1abc | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.39e-05 | 175 | 168 | 6 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.39e-05 | 175 | 168 | 6 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-05 | 176 | 168 | 6 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.56e-05 | 176 | 168 | 6 | 6b1cf1e98b4509e87f9eea827fa7090ce1e504f1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-05 | 176 | 168 | 6 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-GC_B_(II)|lymph-node_spleen / Manually curated celltypes from each tissue | 5.56e-05 | 176 | 168 | 6 | 5788dd5b23ebb52f19d3b5bdbcfe25dee349cf77 | |
| ToppCell | Club_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 5.56e-05 | 176 | 168 | 6 | 88c4ed0ab4a4ede8cad21385d799b723b5786cd9 | |
| ToppCell | facs-Skin-nan-18m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.74e-05 | 177 | 168 | 6 | 17065d37fd41f04f67282bee00365daa185e8355 | |
| ToppCell | facs-Skin-nan-18m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.74e-05 | 177 | 168 | 6 | 6e45e1a5a894ca2e4ebc5cdb17fdf79e9e188185 | |
| ToppCell | facs-Skin-nan-18m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.74e-05 | 177 | 168 | 6 | 9ff3a77c5c62c8a950c46ca22cd7bde425b84c9a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.92e-05 | 178 | 168 | 6 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | RSV-Healthy-0|RSV / Virus stimulation, Condition and Cluster | 6.30e-05 | 180 | 168 | 6 | 974044056e2f7e909cb11c6f6ca89e58bf95f7e5 | |
| ToppCell | facs-SCAT|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-05 | 180 | 168 | 6 | 6c70b6b7480507fa94625013222ad338ee7dd1d9 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.30e-05 | 180 | 168 | 6 | 455d1e3ccf2ab609954f3b870e8f514ddca735f4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.30e-05 | 180 | 168 | 6 | 023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5 | |
| ToppCell | RSV-Healthy-0|Healthy / Virus stimulation, Condition and Cluster | 6.30e-05 | 180 | 168 | 6 | 703a1d0f9536af94d56757eb01221878d7b7fe61 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.49e-05 | 181 | 168 | 6 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.49e-05 | 181 | 168 | 6 | aa233b652921848af2257cc3687a7a09c3acfb67 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.11e-05 | 184 | 168 | 6 | e2de27cee3ea80f9b7a9a7884ceceeaa67b3214a | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.55e-05 | 186 | 168 | 6 | 4046b701aa29712d9f7c774f8955215122c3c003 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.55e-05 | 186 | 168 | 6 | 77592a6397b44b2b59a4fc39d7224dd95343efe6 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.55e-05 | 186 | 168 | 6 | bd5837033c1ffcbe5dd30195cc4846a2ba351bcd | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.77e-05 | 187 | 168 | 6 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.00e-05 | 188 | 168 | 6 | 8268574584e5fb869a6cb8bbd7135cd7454a6a25 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.00e-05 | 188 | 168 | 6 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.00e-05 | 188 | 168 | 6 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.00e-05 | 188 | 168 | 6 | 74f7d216209cabdc96b2d46685b0ae017fdcc8fc | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.00e-05 | 188 | 168 | 6 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.00e-05 | 188 | 168 | 6 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.00e-05 | 188 | 168 | 6 | f54b063025d80de631382bf5326bc40aab7f7d00 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.24e-05 | 189 | 168 | 6 | 287e59104687fe1665232c52993889f0f2c97f17 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 8.24e-05 | 189 | 168 | 6 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | 343B-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.24e-05 | 189 | 168 | 6 | c26428871dc3261327d89cacaba6e21e004ff1f3 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.24e-05 | 189 | 168 | 6 | 6d24414ac6bd4f03f7a5ad3a6eba51d549a7b112 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.24e-05 | 189 | 168 | 6 | a9864873b19ab3e60acf11f288fa7275badc2e42 | |
| ToppCell | COVID-19-Heart-EC_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.24e-05 | 189 | 168 | 6 | fe49852ba15f948b384d6b4c258927c70b741357 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.24e-05 | 189 | 168 | 6 | 222e67d3fd106c43b0cae6538dddeaa7be1f759f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.24e-05 | 189 | 168 | 6 | da9ecc0d7b81c1901f30f97bb44112dc85444a66 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.24e-05 | 189 | 168 | 6 | 532aaf02b364c5c4f58a2021c7c21d86df3875c9 | |
| ToppCell | tumor_Lung-B_lymphocytes-GC_B_cells_in_the_LZ|B_lymphocytes / Location, Cell class and cell subclass | 8.48e-05 | 190 | 168 | 6 | bfb16efb23add53eebabc8e48f20c96994ec01da | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.48e-05 | 190 | 168 | 6 | ed100e271aac82806f59e0c613ccda63f59100c1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.48e-05 | 190 | 168 | 6 | 2f54da2bee411f8868348a4c37034184b8f58a89 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.48e-05 | 190 | 168 | 6 | 59720dfe9de1b980807644536c919d2a02ba69dd | |
| ToppCell | COVID-19-Heart-CM_4|Heart / Disease (COVID-19 only), tissue and cell type | 8.48e-05 | 190 | 168 | 6 | 3729648a17093b438398b82e32bbccc3af7b8c5d | |
| Drug | orthovanadate | ACP6 MYO7A ACTBL2 ACTB ACTG1 CRAT JAK2 DNAI1 PTPN2 PIK3CA SCARB2 TBK1 GET3 ATP2A2 DYNC1H1 ATP5F1B | 1.32e-07 | 435 | 166 | 16 | CID000061672 |
| Drug | Biliton | 4.99e-07 | 41 | 166 | 6 | CID000002974 | |
| Drug | monochloramine | 2.12e-06 | 52 | 166 | 6 | CID000025423 | |
| Drug | plakin | 2.32e-06 | 82 | 166 | 7 | CID000018752 | |
| Drug | nimodipine | 1.15e-05 | 145 | 166 | 8 | CID000004497 | |
| Drug | halazepam | 1.21e-05 | 20 | 166 | 4 | CID000031640 | |
| Drug | caged ATP | 1.22e-05 | 70 | 166 | 6 | CID000123806 | |
| Drug | Mgamp-pnp | 1.48e-05 | 21 | 166 | 4 | CID005311323 | |
| Drug | Chloroquine diphosphate [50-63-5]; Down 200; 7.8uM; PC3; HT_HG-U133A | 1.55e-05 | 198 | 166 | 9 | 7251_DN | |
| Drug | manganese | CACNA1E TREX1 ACTB ITGA6 ACTG1 UPF1 ITGAE CRAT ITGB5 RYR3 PIK3R4 GBA3 FARSA GUCY2C XPNPEP3 GLUL ATP2A2 SOS1 | 2.00e-05 | 791 | 166 | 18 | CID000023930 |
| Drug | genistein | CACNA1E ACTBL2 ACTB ITGA6 ACTG1 ITGAE ITGB5 CLCC1 ZFPM2 RYR3 PIK3R4 JAK2 GBA3 CLCN7 PIK3CA SCGB1A1 UGT2B7 HSD17B1 DYNC1H1 GABRA4 SOS1 GABRA6 | 2.17e-05 | 1117 | 166 | 22 | CID005280961 |
| Disease | Moyamoya disease (implicated_via_orthology) | 6.02e-08 | 8 | 162 | 4 | DOID:13099 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 6.02e-08 | 8 | 162 | 4 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 6.02e-08 | 8 | 162 | 4 | DOID:0081112 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 6.02e-08 | 8 | 162 | 4 | DOID:14004 (implicated_via_orthology) | |
| Disease | intestinal atresia (implicated_via_orthology) | 1.79e-07 | 10 | 162 | 4 | DOID:10486 (implicated_via_orthology) | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 1.79e-07 | 10 | 162 | 4 | DOID:13832 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome | 3.00e-05 | 2 | 162 | 2 | cv:C1853623 | |
| Disease | Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation | 3.00e-05 | 2 | 162 | 2 | C1855722 | |
| Disease | estrogen-receptor positive breast cancer (is_implicated_in) | 3.00e-05 | 2 | 162 | 2 | DOID:0060075 (is_implicated_in) | |
| Disease | Fryns-Aftimos Syndrome | 3.00e-05 | 2 | 162 | 2 | C1853623 | |
| Disease | Sphingomyelin (d18:2/23:0, d18:1/23:1, d17:1/24:1) measurement | 1.78e-04 | 4 | 162 | 2 | EFO_0022116 | |
| Disease | obesity (implicated_via_orthology) | 1.94e-04 | 215 | 162 | 7 | DOID:9970 (implicated_via_orthology) | |
| Disease | Aicardi-Goutieres Syndrome 2 | 4.43e-04 | 6 | 162 | 2 | C3489724 | |
| Disease | AICARDI-GOUTIERES SYNDROME 1 | 4.43e-04 | 6 | 162 | 2 | C0796126 | |
| Disease | Autosomal dominant nonsyndromic hearing loss | 5.34e-04 | 29 | 162 | 3 | cv:C5779548 | |
| Disease | Pseudo-TORCH syndrome | 6.18e-04 | 7 | 162 | 2 | C3489725 | |
| Disease | Stage IV Skin Melanoma | 6.18e-04 | 7 | 162 | 2 | C1321872 | |
| Disease | Solid Neoplasm | 6.18e-04 | 7 | 162 | 2 | C0280100 | |
| Disease | Uveoretinal Coloboma | 6.18e-04 | 7 | 162 | 2 | C4554007 | |
| Disease | Large cell carcinoma of lung | 7.17e-04 | 32 | 162 | 3 | C0345958 | |
| Disease | AICARDI-GOUTIERES SYNDROME | 8.21e-04 | 8 | 162 | 2 | C0393591 | |
| Disease | Pena-Shokeir syndrome type I | 8.21e-04 | 8 | 162 | 2 | C1276035 | |
| Disease | Aicardi-Goutieres syndrome (is_implicated_in) | 1.05e-03 | 9 | 162 | 2 | DOID:0050629 (is_implicated_in) | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 1.05e-03 | 9 | 162 | 2 | EFO_0600040 | |
| Disease | Congenital ocular coloboma (disorder) | 1.05e-03 | 9 | 162 | 2 | C0009363 | |
| Disease | liver cancer (is_marker_for) | 1.05e-03 | 9 | 162 | 2 | DOID:3571 (is_marker_for) | |
| Disease | lymphocyte count | RAPSN POTEF ACTB NOC3L ARHGEF18 EXTL2 DENND3 ZFPM2 SLC45A4 IFIH1 PTPN2 DCLRE1C SCGB1A1 USP7 TADA2A UBASH3B NEURL4 NOTCH2 | 1.18e-03 | 1464 | 162 | 18 | EFO_0004587 |
| Disease | dipeptidase 2 measurement | 1.31e-03 | 10 | 162 | 2 | EFO_0801528 | |
| Disease | Congenital neurologic anomalies | 1.31e-03 | 10 | 162 | 2 | C0497552 | |
| Disease | Cranioschisis | 1.31e-03 | 10 | 162 | 2 | C0265541 | |
| Disease | mean platelet volume | ARHGAP32 RAPSN ITGA6 NFASC FRYL ZFPM2 SLC45A4 JAK2 CYRIA BTD SYNE2 USP7 UBASH3B ATP5F1B | 1.55e-03 | 1020 | 162 | 14 | EFO_0004584 |
| Disease | spontaneous preterm birth, parental genotype effect measurement | 1.59e-03 | 11 | 162 | 2 | EFO_0005939, EFO_0006917 | |
| Disease | level of Sphingomyelin (d34:0) in blood serum | 1.59e-03 | 11 | 162 | 2 | OBA_2045176 | |
| Disease | serum albumin measurement | DNAJC13 RAPSN RBMS2 CLOCK ITIH1 SLC45A4 ABCA5 CPT1C UBASH3B SOS1 | 1.67e-03 | 592 | 162 | 10 | EFO_0004535 |
| Disease | level of Phosphatidylinositol (16:0_18:1) in blood serum | 1.91e-03 | 12 | 162 | 2 | OBA_2045152 | |
| Disease | myeloid white cell count | SLC25A24 DNAJC13 RAPSN EXTL2 ZFPM2 SLC45A4 IFIH1 CYRIA TADA2A UBASH3B ATP2A2 NOTCH2 RASAL2 | 2.06e-03 | 937 | 162 | 13 | EFO_0007988 |
| Disease | epilepsy (implicated_via_orthology) | 2.11e-03 | 163 | 162 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | hearing impairment | 2.12e-03 | 98 | 162 | 4 | C1384666 | |
| Disease | X-19141 measurement | 2.25e-03 | 13 | 162 | 2 | EFO_0800799 | |
| Disease | type 1 diabetes mellitus | 2.26e-03 | 242 | 162 | 6 | MONDO_0005147 | |
| Disease | platelet crit | STARD13 RAPSN NOC3L ZFPM2 SLC45A4 NUP205 JAK2 FARSA USP7 CHRDL1 TADA2A UBASH3B RASAL2 | 2.37e-03 | 952 | 162 | 13 | EFO_0007985 |
| Disease | Malignant neoplasm of breast | DDX59 PIK3R4 HOXA4 ARAP3 PER2 PIK3CA ZNF436 SYNE2 PRKAA1 ZFYVE26 DMD NOTCH2 RASAL2 GABRA4 | 2.48e-03 | 1074 | 162 | 14 | C0006142 |
| Disease | glycerophospholipid measurement | 2.49e-03 | 49 | 162 | 3 | EFO_0007630 | |
| Disease | calcium measurement | MBOAT2 ITIH1 HEPH ZFPM2 GRHL1 SYNE2 UBASH3B ATP2A2 MVB12B SOS1 | 2.56e-03 | 628 | 162 | 10 | EFO_0004838 |
| Disease | Malformations of Cortical Development | 2.61e-03 | 14 | 162 | 2 | C1955869 | |
| Disease | Cortical Dysplasia | 2.61e-03 | 14 | 162 | 2 | C0431380 | |
| Disease | Mental Depression | 2.87e-03 | 254 | 162 | 6 | C0011570 | |
| Disease | Influenza | 2.95e-03 | 52 | 162 | 3 | C0021400 | |
| Disease | mean corpuscular hemoglobin concentration | DNAJC13 RAPSN GPAA1 POTEF ACTB ITGB5 CYRIA PIK3CA TBK1 PRKAA1 SEC16A PAN3 USF2 SLC22A20P | 3.20e-03 | 1105 | 162 | 14 | EFO_0004528 |
| Disease | skin aging measurement | 3.31e-03 | 181 | 162 | 5 | EFO_0008006 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 3.39e-03 | 447 | 162 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | Tremor, Rubral | 3.42e-03 | 16 | 162 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 3.42e-03 | 16 | 162 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 3.42e-03 | 16 | 162 | 2 | C0278161 | |
| Disease | Ataxia, Sensory | 3.42e-03 | 16 | 162 | 2 | C0240991 | |
| Disease | Abnormal coordination | 3.42e-03 | 16 | 162 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 3.42e-03 | 16 | 162 | 2 | C0427190 | |
| Disease | peanut allergy measurement | 3.42e-03 | 16 | 162 | 2 | EFO_0007017 | |
| Disease | succinylcarnitine measurement | 3.42e-03 | 16 | 162 | 2 | EFO_0020020 | |
| Disease | Diffuse Large B-Cell Lymphoma | 3.46e-03 | 55 | 162 | 3 | C0079744 | |
| Disease | Schizophrenia | ANKK1 ARHGAP32 ABCA13 ACTB NFASC CLOCK ITIH1 PIK3CA GLUL ATP2A2 GABRA4 GABRA6 | 3.60e-03 | 883 | 162 | 12 | C0036341 |
| Disease | heart disease (biomarker_via_orthology) | 3.86e-03 | 17 | 162 | 2 | DOID:114 (biomarker_via_orthology) | |
| Disease | phosphatidylcholine 36:4 measurement | 4.33e-03 | 18 | 162 | 2 | EFO_0010382 | |
| Disease | Carcinoma of bladder | 4.33e-03 | 18 | 162 | 2 | C0699885 | |
| Disease | disease progression measurement | 4.63e-03 | 61 | 162 | 3 | EFO_0008336 | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 4.82e-03 | 19 | 162 | 2 | C3501846 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 4.82e-03 | 19 | 162 | 2 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 4.82e-03 | 19 | 162 | 2 | C1275081 | |
| Disease | Costello syndrome (disorder) | 4.82e-03 | 19 | 162 | 2 | C0587248 | |
| Disease | level of Sterol ester (27:1/20:3) in blood serum | 4.82e-03 | 19 | 162 | 2 | OBA_2045199 | |
| Disease | leukemia (implicated_via_orthology) | 4.82e-03 | 19 | 162 | 2 | DOID:1240 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | 5.00e-03 | 477 | 162 | 8 | C0005586 | |
| Disease | lymphocyte:monocyte ratio | 5.28e-03 | 288 | 162 | 6 | EFO_0600088 | |
| Disease | X-24309 measurement | 5.33e-03 | 20 | 162 | 2 | EFO_0800872 | |
| Disease | alpha-tocopherol measurement | 5.33e-03 | 20 | 162 | 2 | EFO_0007898 | |
| Disease | Depressive disorder | 5.37e-03 | 289 | 162 | 6 | C0011581 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FFPDMIPVSSIYMDS | 141 | Q8WWZ7 | |
| IVTAMPPYFAMENAE | 1031 | Q8WWZ7 | |
| GVSVDMNITYMSPAK | 81 | Q9NPJ3 | |
| MFLISASLQGPEMYE | 751 | Q6ZSZ5 | |
| MTLDTLSIYETPSMG | 441 | P55884 | |
| YMATMAAQGVPESLR | 186 | Q86VW2 | |
| TVEMMPNSIYFGLDS | 151 | Q8WWN8 | |
| VSPSFEYTIMAMIAL | 1476 | Q15878 | |
| TFPYGMVTMALVDAN | 216 | Q8TDN7 | |
| MSTMCSPYSVGVVQD | 311 | Q9UKQ2 | |
| TQIMFEAFNTPAMYV | 121 | Q562R1 | |
| ENHYFASSMLPTMEA | 116 | Q5NE16 | |
| QIMFETFNTPAMYVA | 121 | Q9BYX7 | |
| QIMFETFNTPAMYVA | 121 | P60709 | |
| QIMFETFNTPAMYVA | 121 | P63261 | |
| NETGSLHSVSPYFMM | 76 | Q9Y3Q7 | |
| GMLSYIPPEMFLESN | 186 | Q8NFD2 | |
| MSYPDVSAMILDASF | 366 | O95870 | |
| QNIYISPQMGSMTFE | 331 | A8K2U0 | |
| NSDIFSMSPSILSYM | 2611 | Q86UQ4 | |
| LVSMPDIFMDTSYAI | 531 | P43155 | |
| PSGDASSLSKNIMMY | 551 | Q8TDJ6 | |
| PEYMFSSNSGVMCLD | 376 | Q9UI46 | |
| FDTLPPMRYQETMSA | 936 | P11532 | |
| GLTPEYMEMIIQFGF | 741 | Q9NQ90 | |
| PSNVYSCSMDGMVLV | 1001 | A2RUS2 | |
| DPTPDYMNLLGMIFS | 31 | Q9Y284 | |
| YQPTLATDMGTMQER | 331 | P06576 | |
| MPLLTSTNEFYTKGM | 461 | Q04656 | |
| NFSMIIDGMTYPGII | 81 | Q14624 | |
| NTSVAPMMNPFIYSL | 276 | Q96RD1 | |
| FPRYDSAMSIMTEIG | 266 | Q13702 | |
| NADMGVMALTYDPTT | 241 | Q15434 | |
| MYLDTELSYPMISAG | 131 | P25092 | |
| GITPVYHNMFALMSE | 76 | O60674 | |
| PGEAASMSMFSDFLQ | 146 | P57740 | |
| MGLIQTPDQLRFSYM | 256 | P17706 | |
| MEYCQSLMLQSSPTF | 1761 | Q92621 | |
| EANLDQPVTMIFMGY | 271 | Q8IXS6 | |
| SEQFLSTMVPPGVYM | 326 | Q9NRD9 | |
| ETQYNEMFGMVLAPA | 2261 | Q04721 | |
| QIMFETFNTPAMYVA | 821 | A5A3E0 | |
| DINDTEPVTMIFMGY | 406 | Q9NP74 | |
| AFMYLQPSSISSMDQ | 256 | Q15617 | |
| AFMYLQPSSVSSMDQ | 291 | Q8NG78 | |
| EMANRMSLFYAEATP | 181 | Q9H0Q0 | |
| YSADFSGPMMIITQK | 126 | Q6ZWT7 | |
| FPPLTQRTYMSENAM | 41 | O43292 | |
| MSLDYGFVTPLTSMS | 596 | P19827 | |
| LQAASQMTLTEGMYP | 206 | Q8WW38 | |
| AQNLVDLPMFSVYMS | 206 | P14091 | |
| DLPMFSVYMSSNPEG | 211 | P14091 | |
| LVVNFDMPSSMDEYV | 516 | Q5T1V6 | |
| SMPLRYSNIMISQFG | 306 | Q9UBQ6 | |
| MEATSNVTYGFPIML | 571 | P51798 | |
| SGEDSYMTSMALNYP | 861 | P38570 | |
| ADADSSVMMTYQLPS | 1141 | O15055 | |
| DMCFTTGSIPQMLYN | 76 | Q8NHA6 | |
| PMYFLLGNLSFVDMT | 61 | Q8NGC6 | |
| MESSLCVMANPTYDI | 1176 | Q9H792 | |
| GMYDVQSTTEPTNLM | 1986 | O94915 | |
| IMSPSLFNLMQEYPD | 486 | Q9UJF2 | |
| VPQDGTMLTALHSYM | 316 | Q68G74 | |
| TSFGPVSDVEMEYTM | 81 | P48169 | |
| SFGPVSDVEMEYTMD | 66 | Q16445 | |
| TPEYMEMIIQFGFVT | 726 | Q5XXA6 | |
| DTFPDVMMNSYLGFS | 286 | P23229 | |
| SFRGYSSEIQMMTLP | 1041 | Q9NQV6 | |
| TAMSRGLYQPATIFM | 146 | Q2M2Z5 | |
| LYFMVTGTMPFRAET | 261 | Q8IY84 | |
| DSPESVTQMLMAYLS | 206 | A7KAX9 | |
| VMMFTYVELPSGKSN | 691 | P18084 | |
| ESLYSQLPMDCFTMP | 291 | P42336 | |
| SNLYAISAMDGVPFM | 246 | Q9H7P6 | |
| MLESNYTMPTEFLFV | 1 | Q8N127 | |
| FGIAMVVYMVPDSNQ | 251 | Q6IF42 | |
| MAMSSFLINSNYVDP | 1 | P17483 | |
| DMAYSSSVTPNMLVN | 66 | Q8WZ92 | |
| QIMFETFNTPAMYVA | 821 | Q6S8J3 | |
| SVNDIMPMIGARFYT | 741 | Q58A45 | |
| FMYPQGTASSQMVLR | 246 | O94856 | |
| PSSMYFQTHDQIGMI | 966 | Q92900 | |
| MMDFLYVTPTPLQAA | 256 | Q8TCG5 | |
| DCAIFESPYPMTMAL | 886 | P16615 | |
| DAEMYTNMSVLTPFT | 496 | Q04446 | |
| FLTSLPQEMVSYMPD | 196 | Q6WRI0 | |
| MTSYMAIDGSALVPL | 1 | Q8WWN9 | |
| SLRMPGMNSEDYVFD | 231 | Q9NZI5 | |
| MSSFEGQMAEYPTIS | 1 | Q96SD1 | |
| NEPMEAFVGEMTSYT | 2156 | Q99715 | |
| FCGEETMPVYESVFM | 341 | Q9BU40 | |
| TMPVYESVFMEDGET | 346 | Q9BU40 | |
| ANVLSVMSYDLGMFP | 166 | Q9H227 | |
| MRLDDPSGSNYVTAM | 266 | P14061 | |
| PVSMAASFEDGLYMQ | 331 | Q3B7J2 | |
| VNMYAMLTGTLPFTV | 251 | P57058 | |
| IQTYCQMSPMSDFGT | 561 | Q9BYX4 | |
| PPTFHSEMMYDNFTL | 391 | P43251 | |
| FFIMMYTGSNVLPVA | 1126 | O75165 | |
| EMGMTFSSAYVPSAL | 76 | P15586 | |
| MSAFPGIDEAMSYAE | 136 | O43681 | |
| AEPLTAAMVEFYTMS | 2766 | Q14204 | |
| YNTTELVMMQDSSPD | 251 | O75208 | |
| PILGDFSNAHMIMYS | 1311 | Q9Y4K1 | |
| FTGELYPTEIRQMGM | 446 | A6NK97 | |
| MTMSSFLINSNYIEP | 1 | Q00056 | |
| EYPATMTNLQSGTIM | 391 | Q96JN8 | |
| CYNPMMEDGISYTTL | 751 | P20273 | |
| MEDGISYTTLRFPEM | 756 | P20273 | |
| FEAYSMAEMTFNPPV | 736 | Q8WTT2 | |
| YIEVIFNSAMTPAMA | 1016 | O14654 | |
| MPSASAMIIFNLSSY | 1 | Q8NGJ2 | |
| MNPDYTKLTMDLGST | 31 | Q92570 | |
| AFMYLQPSSVSSMDQ | 256 | P0DMU2 | |
| EGSNSDMYLVPAAMF | 71 | P15104 | |
| YEMPEFSSDSTMRIL | 101 | Q96DX8 | |
| GEPSLYNSLSMAMQT | 141 | Q6P1K8 | |
| LNSMTPEGQEMYLRF | 16 | Q9Y3M8 | |
| SEAMLQATCGTPIYM | 276 | Q9BYT3 | |
| QIFLEMGFTEMPTDN | 236 | Q9Y285 | |
| MGFTEMPTDNFIESS | 241 | Q9Y285 | |
| YSQDMTGVTPFQMIF | 96 | Q8N6T0 | |
| STNMGILPSVTMYNF | 4476 | Q8WXH0 | |
| TFDSLLSRDMAGYMP | 156 | O75478 | |
| GAAASVMYTVVTPML | 271 | O76100 | |
| FQMFSRNPYMPETSD | 286 | Q9NXP7 | |
| TFVMAIMQPDNLGTF | 681 | Q9BQS7 | |
| MFETFNTPAMYVAIQ | 786 | P0CG39 | |
| VETGDIRTMVFPVMY | 396 | Q14108 | |
| MSMLPSFGFTQEQVA | 1 | Q15475 | |
| QIMFETFNTPAMYVA | 821 | P0CG38 | |
| TFNTPAMYVAIQAML | 826 | P0CG38 | |
| PMSAAMFLGYELSLQ | 286 | Q6ZT89 | |
| VMTFPYFTGLSMLSA | 101 | Q96LA9 | |
| PMGNSMEKEFTDYLF | 996 | Q07889 | |
| NFNMSVSSMEYIPEG | 181 | Q9Y3F4 | |
| YQVISTPSDIFMVME | 91 | Q13131 | |
| LYNTMVISQPAAGSM | 661 | O15516 | |
| PTDMLNYDAASGTMR | 26 | Q96S66 | |
| LGREVMSPLQAMSSY | 26 | Q9BYT8 | |
| GMFATELEYMRDPST | 206 | Q99570 | |
| FPNVYVAMVTISTMG | 611 | Q5BKX6 | |
| MDTPSSYEAAMELFS | 36 | P11684 | |
| LMPQVSYGASMELLS | 161 | Q7RTX0 | |
| TPFEFENMAESTGMY | 671 | Q6NZY4 | |
| QAPVTFEDMAMYLTR | 11 | Q9C0F3 | |
| MGPLTFMDVAIEFSV | 1 | A8MTY0 | |
| QISQTDLFGNPMMYD | 681 | Q05086 | |
| QTVYQLMSGRMPAAS | 1676 | O15027 | |
| ASMMYLENGTPDTAA | 101 | Q99747 | |
| PSYVPVVMSELSDQM | 191 | P06133 | |
| AYLATADMPAMSTRD | 371 | Q9NXZ1 | |
| MVFFVLQESTGYMAP | 4461 | Q15413 | |
| APVSEYMNQAMLFGR | 476 | Q9BSA4 | |
| SEMMYDSDVPFQIVV | 1496 | Q9HCK1 | |
| DMFLNAMSVYTLSPE | 396 | Q9NPH0 | |
| IFTSNTYVMVVMSDP | 326 | Q5VZM2 | |
| FYVMMTPQDVLQTGT | 196 | Q15853 | |
| MSMLPTFGFTQEQVA | 1 | Q9NPC8 | |
| MMTAVNGVAVTEYDP | 1066 | O60290 | |
| PMNMLSVLRAYSSDG | 1261 | O15090 | |
| LLTTANFPDVMMPSY | 276 | Q9ULQ1 | |
| MGPLTFMDVAIEFSL | 1 | P17019 | |
| SAIAIALMTFGTMYP | 231 | Q6NXT4 | |
| NMEPYTVSGMARQDS | 1911 | Q9UPU5 | |
| FPGTSLENIYSMMLT | 376 | Q9NQH7 | |
| VLYVMVTGCMPFDDS | 201 | Q9BXA6 | |
| VPGDFIFMSPMEQTS | 276 | Q8TF42 | |
| PSYVPVVMSELTDQM | 191 | P16662 | |
| TYMSQAFQLPESEMP | 606 | Q2TAA8 | |
| MQTLIFFDMEATGLP | 11 | Q9NSU2 | |
| AVYMMPTEGDDSSKS | 241 | Q93009 | |
| SPSSGELMFMERYQE | 861 | Q68DK2 | |
| YMSMTEPSQDYVPAS | 41 | O94900 | |
| SMAGATAQTFIYPME | 296 | Q6NUK1 | |
| IYPSSNTLVEMTLGM | 676 | Q9UHD2 | |
| DFPTDSVYVMPTVTM | 1661 | Q13402 |